#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Mark Dybul Email
CEO & Director . Enochian BioSciences
How to contact Mark Dybul
Join and see Mark's contact info for free!Current Roles
Employees:
17Revenue:
$2.6MAbout
Enochian BioSciences (formerly DanDrit Biotech USA Inc.) a biopharmaceutical company, focuses on the development and commercialization of novel therapies aimed to change the course of immunotherapy treatments for HIV/AIDS and cancer. The company's lead candidate ENO-1001 (pre-IND) is a potentially sterilizing cure for HIV/AIDS. ENO-2001 is an HIV vaccine in preclinical stage, and its additional compounds ENO-4001 (phase three asset), ENO-4002, ENO-5001, and ENO-3001 are in discovery stages for prevention relapse in colon cancer patients. Enochian BioSciences is headquartered in Los Angeles, California.Enochian BioSciences Address
4142 Lankershim BlvdLos Angeles, CA
United States